segmentation

Digital

Synthetic personas turn static, traditional personas into interactive, evidence-backed simulations.

Views & Analysis

Dividing patients into groups based on how they behave towards their condition aids understanding.

News

Astellas takes an option on a cancer immunotherapy developed by Audax for up to $1.34bn, with Gilead and Teva also adding to their pipelines.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.